STOCK TITAN

Outset Medical to Present at the 2024 Stifel Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Outset Medical (Nasdaq: OM), a medical technology company focused on revolutionizing dialysis through innovative technology, has announced its participation in the 2024 Stifel Healthcare Conference. The company's management team will deliver a presentation on Tuesday, November 19, 2024, at 10:20 a.m. Eastern time. Interested parties can access both the live presentation and archived recording through the 'Investors' section of Outset's website at investors.outsetmedical.com.

Outset Medical (Nasdaq: OM), un'azienda di tecnologia medica focalizzata sulla rivoluzione della dialisi attraverso innovazioni tecnologiche, ha annunciato la sua partecipazione alla Conferenza Sanitaria Stifel 2024. Il team di gestione dell'azienda presenterà martedì 19 novembre 2024, alle 10:20 ora orientale. Le parti interessate possono accedere sia alla presentazione in diretta che alla registrazione archiviata attraverso la sezione 'Investitori' del sito web di Outset all'indirizzo investors.outsetmedical.com.

Outset Medical (Nasdaq: OM), una empresa de tecnología médica centrada en revolucionar la diálisis a través de tecnología innovadora, ha anunciado su participación en la Conferencia de Salud Stifel 2024. El equipo de gestión de la empresa ofrecerá una presentación el martes 19 de noviembre de 2024, a las 10:20 a.m. hora del Este. Las partes interesadas pueden acceder tanto a la presentación en vivo como a la grabación archiva a través de la sección 'Inversores' en el sitio web de Outset en investors.outsetmedical.com.

아우셋 메디컬 (Nasdaq: OM)은 혁신적인 기술을 통해 투석 분야의 혁신을 목표로 하는 의료 기술 회사로, 2024 스티펠 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사의 경영진은 2024년 11월 19일 화요일 동부 시간으로 오전 10시 20분에 발표를 할 예정입니다. 관심 있는 분들은 아우셋의 웹사이트 '투자자' 섹션에서 실시간 발표 및 기록된 아카이브에 접근할 수 있습니다: investors.outsetmedical.com.

Outset Medical (Nasdaq: OM), une entreprise de technologie médicale axée sur la révolution de la dialyse grâce à une technologie innovante, a annoncé sa participation à la Conférence Santé Stifel 2024. L'équipe de direction de l'entreprise présentera le mardi 19 novembre 2024, à 10h20, heure de l'Est. Les parties intéressées peuvent accéder à la fois à la présentation en direct et à l'enregistrement archivé via la section 'Investisseurs' du site Web d'Outset à l'adresse investors.outsetmedical.com.

Outset Medical (Nasdaq: OM), ein Medizintechnikunternehmen, das sich auf die Revolutionierung der Dialyse durch innovative Technologie konzentriert, hat seine Teilnahme an der Stifel Healthcare Conference 2024 angekündigt. Das Management-Team des Unternehmens wird am Dienstag, den 19. November 2024, um 10:20 Uhr Eastern Time eine Präsentation halten. Interessierte Parteien können sowohl die Live-Präsentation als auch die archivierte Aufzeichnung im Bereich 'Investoren' der Website von Outset unter investors.outsetmedical.com abrufen.

Positive
  • None.
Negative
  • None.

SAN JOSE, Calif., Nov. 15, 2024 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will present at the 2024 Stifel Healthcare conference on Tuesday, November 19, 2024, at 10:20 a.m. Eastern time.

A live and archived webcast of the presentation will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.
Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo® Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

Contact
Jim Mazzola
Investor Relations
jmazzola@outsetmedical.com


FAQ

When is Outset Medical (OM) presenting at the 2024 Stifel Healthcare Conference?

Outset Medical (OM) is scheduled to present at the 2024 Stifel Healthcare Conference on Tuesday, November 19, 2024, at 10:20 a.m. Eastern time.

How can I watch Outset Medical's (OM) presentation at the Stifel Healthcare Conference?

You can watch both the live and archived webcast of Outset Medical's presentation through the 'Investors' section of their website at investors.outsetmedical.com.

What is the focus of Outset Medical's (OM) technology?

Outset Medical focuses on pioneering first-of-its-kind technology aimed at reducing the cost and complexity of dialysis treatment.

Where will the 2024 Stifel Healthcare Conference presentation by Outset Medical (OM) be available?

The presentation will be available on the 'Investors' section of the Outset Medical website at investors.outsetmedical.com.

Outset Medical, Inc.

NASDAQ:OM

OM Rankings

OM Latest News

OM Stock Data

42.14M
52.54M
2.15%
95.97%
6.66%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
SAN JOSE